Version 2.0 of the Tuberculosis Therapeutic Area User Guide (TAUG-TB) was developed under the CFAST Program and the CDISC Standards Development Process. The TAUG-TB describes the most common biomedical concepts relevant to tuberculosis studies, and the necessary metadata to represent such data consistently with Terminology and SDTM.
TA Standards extend the Foundational Standards to represent data that pertain to specific indications within disease areas. CDISC Standards specify how to structure the data; they do not specify what data should be collected or how to conduct clinical trials, assessments or endpoints.
CDISC posts Public Review comments and resolutions to ensure transparency and show implementers how comments were addressed in the standard development process.
This project was made possible by the generous support of the Bill & Melinda Gates Foundation.
| Attachment | Size |
|---|---|
 Tuberculosis Therapeutic Area User Guide v2 | 3.86 MB |
 TA Spec-TB v2 | 35.44 KB |
| CDISC Tuberculosis v2 Public Review Comment | 47.43 KB |
The Critical Path Institute used CDISC standards to create an aggregated TB Clinical Trial Data-Sharing Platform to enable more efficient and effective drug development
